Clovis Oncology reported $24.99M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 10.79M 0.48M
Arrowhead Research ARWR:US 0 0
Clovis Oncology CLVS:US $ 24.99M 2.83M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Esperion Therapeutics ESPR:US $ 23.71M 3.68M
GlaxoSmithKline GSK:LN 6330M 114M
Halozyme Therapeutics HALO:US $ 58.55M 0.21M
Heron Therapeutics HRTX:US $ 42.8M 0.17M
Intrexon XON:US $ 11.41M 0.78M
Ligand Pharmaceuticals LGND:US $ 39.95M 3.01M
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Novartis NOVN:VX SF 7111M 114M
Puma Biotechnology PBYI:US $ 7.62M 0.12M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
Veracyte VCYT:US $ 6.67M 0.37M
YTE INCY:US $ 16.68M 0.02M